menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Dr. Maya Guglin explains the pathophysiology of hypertrophic cardiomyopathy (HCM) and discusses what the results of the long-term extension study of EXPLORER-HCM could mean for patients with symptomatic obstructive HCM.

Facebook Comments

Recommended
Details
Comments
  • Overview

    Dr. Maya Guglin explains the pathophysiology of hypertrophic cardiomyopathy (HCM) and discusses what the results of the long-term extension study of EXPLORER-HCM could mean for patients with symptomatic obstructive HCM.

Facebook Comments

Schedule16 Apr 2024